The abstract is read at the publisher; the summary is JClub's.
M1, a natural Getah-like alphavirus, shows oncolytic activity against osteosarcoma by disrupting RPB1-driven super-enhancer transcription via NSP2-mediated RPB1 degradation.
- Why it matters: Oncolytic virotherapy is promising but underexplored in osteosarcoma, and the mechanisms linking viral infection to oncogenic transcriptional control remain unclear.
- What they did: Osteosarcoma cells were infected with M1, and proteomic plus ChIP-seq analyses identified RPB1 as a direct target; oncolytic potency correlated with RPB1 transcriptional dependency in super-enhancer regions.
- The result: NSP2 disrupted super-enhancer activity by recruiting the CUL2-RBX1-ELOC complex, triggering K63-linked ubiquitination and degradation of RPB1, supporting further preclinical evaluation and suggesting RPB1 as a biomarker.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.